#217 COVID Cakes the Fourth: ACTT-1, Triple Therapy, PCR, Serology
Jun 01, 2020, 07:00 AM
Stay current with the emerging COVID-19 research including: ACTT-1 (remdesivir), triple therapy with interferon, and conundrums about SARS-CoV-2 PCR and serologic testing. We’re led by the one and only Curbsider/internist/epidemiologist, Rahul Ganatra MD MPH (@rbganatr). And...just in case you live outside of the habitat for murder hornets and your anxiety about the pandemic had begun to abate, we touch on the CDCs guidance to beware of hungry aggressive rats. Gross!
Show Notes | Spotify | Swag! | Top Picks | Mailing List | thecurbsiders@gmail.com | CME!
Credits
- Written and Produced by: Rahul Ganatra MD, MPH, Deborah J. Gorth ScM, Emi Okamoto MD, Sarah P. Roberts MPH, and Matthew Watto MD
- Cover Art: Deborah J. Gorth ScM
- Hosts: Matthew Watto MD, Rahul Ganatra MD MPH, Emi Okamoto MD, and Sarah P. Roberts MPH
- Editor: Matthew Watto MD (written materials); Clair Morgan of nodderly.com
Sponsors: ACP and VCU Health CE
Time Stamps
-
00:00 Sponsors
-
00:30 Intro, disclaimer
-
02:40 Fomites, groceries and killer rats
-
08:22 Sponsor
-
09:22 ACTT-1 trial of remdesivir
-
18:22 Triple therapy with lopinavir/ritonavir, ribavarin and interferon
-
33:10 Background on PCR testing for SARS-CoV-2; How common are false negative PCR tests?
- 44:25 Serologic testing for SARS-CoV-2; Utility of antibody testing; Test characteristics
- 50:30 Outro